Marginal effects of glucose, insulin and insulin‑like growth factor on chemotherapy response in endothelial and colorectal cancer cells

  • Authors:
    • Ekaterina Volkova
    • Bridget A. Robinson
    • Jinny Willis
    • Margaret J. Currie
    • Gabi U. Dachs
  • View Affiliations

  • Published online on: November 27, 2013     https://doi.org/10.3892/ol.2013.1710
  • Pages: 311-320
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Resistance to chemotherapy is a major clinical issue for patients with colorectal cancer. Obesity has been associated with a poorer outcome and is a possible mechanism of resistance. The aim of the present study was to investigate the effect of obesity‑related factors on the cell response to standard chemotherapy in stromal and colorectal cancer cells. Viability was measured following the treatment of colorectal cancer cell lines (WiDr and SW620) and stromal cells (human microvascular endothelial cells) in vitro with 5‑fluorouracil, irinotecan and oxaliplatin under obesity‑related conditions [elevated levels of insulin, insulin‑like growth factor‑1 (IGF‑1) and glucose] and compared with non‑elevated conditions. Obesity‑related conditions alone increased cell viability and in selected cases, accumulation of the transcription factor, hypoxia‑inducible factor‑1. However, these conditions did not consistently increase resistance to the chemotherapy agents tested. The combination of IGF‑1 and extremely low‑dose chemotherapy significantly induced cell viability in WiDr colorectal cancer cells. These in vitro results may have clinical importance in an environment of increasing rates of obesity and colorectal cancer, and the frequent under‑dosing of obese cancer patients.
View Figures
View References

Related Articles

Journal Cover

2014-February
Volume 7 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Volkova E, Robinson BA, Willis J, Currie MJ and Dachs GU: Marginal effects of glucose, insulin and insulin‑like growth factor on chemotherapy response in endothelial and colorectal cancer cells. Oncol Lett 7: 311-320, 2014.
APA
Volkova, E., Robinson, B.A., Willis, J., Currie, M.J., & Dachs, G.U. (2014). Marginal effects of glucose, insulin and insulin‑like growth factor on chemotherapy response in endothelial and colorectal cancer cells. Oncology Letters, 7, 311-320. https://doi.org/10.3892/ol.2013.1710
MLA
Volkova, E., Robinson, B. A., Willis, J., Currie, M. J., Dachs, G. U."Marginal effects of glucose, insulin and insulin‑like growth factor on chemotherapy response in endothelial and colorectal cancer cells". Oncology Letters 7.2 (2014): 311-320.
Chicago
Volkova, E., Robinson, B. A., Willis, J., Currie, M. J., Dachs, G. U."Marginal effects of glucose, insulin and insulin‑like growth factor on chemotherapy response in endothelial and colorectal cancer cells". Oncology Letters 7, no. 2 (2014): 311-320. https://doi.org/10.3892/ol.2013.1710